Your session is about to expire
← Back to Search
DFDBA Particles with DBBM for Jawbone Loss
Study Summary
This trial will test if adding DFDBA fibers to DBBM results in more new bone than adding DFDBA particles to DBBM during a sinus augmentation procedure.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Am I eligible to participate in this medical experiment?
"This clinical trial is currently enrolling a maximum of 26 patients who have suffered jawbone loss and are aged between 18-89."
Can adults over the age of 45 partake in this medical experiment?
"This research trial is welcoming participants over the age of 18 and those under 89 years old."
What is the upper limit for enrolling participants in this clinical trial?
"Affirmative. According to the clinicaltrials.gov repository, this clinical investigation began on September 25th 2023 and is presently in search of 26 patients for enrollment from a single medical institution."
Are there still opportunities for patients to enroll in this experiment?
"Affirmative. According to the clinicaltrials.gov database, this medical study is currently seeking participants. The trial was first posted on September 25th 2023 and has since been updated on December 7th of that same year. This research requires 26 individuals from a single site for successful completion."
Who else is applying?
What portion of applicants met pre-screening criteria?
What site did they apply to?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger